Advertisement
Screener

VIEMED HEALTHCARE, INC. (VMD) EBITDA

VIEMED HEALTHCARE, INC. (VMD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $11.98M*; Operating income $4.46M; Depreciation and amortization $7.52M*.
  • 2026-03-31: Basis Reported; EBITDA $11.92M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $15.94M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $13.18M*; Operating income $5.64M; Depreciation and amortization $7.54M*.

Complete source-backed ebitda history.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$11.98M*$4.46M$7.52M*(m)(m)$8.46M*$15.90M*$33.05M$504.00K$37.13M$1.15M
2026-03-31Reported$11.92M(m)(m)(m)15.80%$6.71M$8.07M$32.59M$579.00K$34.79M$1.28M
2025-12-31Reported$15.94M(m)(m)(m)20.93%(m)(m)(m)(m)(m)(m)
2025-09-30Reported$13.18M*$5.64M$7.54M*(m)(m)$7.64M*$18.37M*$30.57M$775.00K$31.92M$1.53M
2025-06-30Reported$11.99M*$5.09M$6.89M*(m)(m)$8.13M*$12.25M*$26.32M$847.00K$28.80M$1.71M
2025-03-31Reported$10.45M(m)(m)(m)17.68%$15.48M$2.85M$25.85M$797.00K$28.43M$952.00K
2024-12-31Reported$12.82M(m)(m)(m)21.12%(m)(m)(m)(m)(m)(m)
2024-09-30Reported$12.04M*$5.63M$6.41M*(m)(m)$11.00M*$12.74M*$23.63M$757.00K$26.67M$1.59M
2024-06-30Reported$9.93M*$3.62M$6.31M*(m)(m)$8.93M*$10.18M*$22.07M$758.00K$26.50M$768.00K
2024-03-31Reported$8.49M(m)(m)(m)16.78%$6.01M$1.18M$20.79M$750.00K$24.81M$518.00K
2023-12-31Reported$11.21M(m)(m)(m)22.09%(m)(m)(m)(m)(m)(m)
2023-09-30Reported$10.18M*$4.21M$5.97M*(m)(m)$7.40M*$13.81M*$18.84M$593.00K$23.65M$1.32M
2023-06-30Reported$8.11M*$2.90M$5.21M*(m)(m)$6.08M*$7.62M*$17.20M$758.00K$20.56M$728.00K
2023-03-31Reported$6.7M(m)(m)(m)16.93%$4.68M$10.50M$15.55M$780.00K$19.76M$501.00K
2022-09-30Reported(m)$1.47M(m)(m)(m)$6.34M*$7.97M*$14.11M$670.00K$17.68M$456.00K
2022-06-30Reported(m)$1.00M(m)(m)(m)$7.03M*$4.95M*$12.92M$672.00K$17.54M$421.00K
2022-03-31Reported(m)$2.25M(m)(m)(m)$3.96M$7.15M$12.51M$632.00K$15.78M$745.00K
2021-09-30Reported(m)$2.92M(m)(m)(m)$8.03M*$5.03M*$10.90M$576.00K$13.26M$1.39M
2021-06-30Reported(m)$2.66M(m)(m)(m)$3.25M*$4.18M*$9.77M$583.00K$12.88M$1.25M
2021-03-31Reported(m)$1.33M(m)(m)(m)$1.80M$4.63M$10.67M$339.00K$14.51M-$223.00K
2020-12-31Reported(m)$5.27M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Reported(m)$4.04M(m)(m)(m)$2.48M*$7.33M*$13.99M$243.00K$13.55M$1.14M
2020-06-30Reported(m)$12.86M(m)(m)(m)$1.51M*$21.38M*$16.93M$271.00K$16.43M-$6.65M
2020-03-31Reported(m)$4.62M(m)(m)(m)$4.22M$607.00K$8.25M$174.00K$10.58M$187.00K
2019-12-31Reported(m)$2.69M(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Reported(m)$2.19M(m)(m)(m)$2.88M*$5.72M*$6.32M$208.00K$10.23M$51.00K
2019-06-30Reported(m)$1.66M(m)(m)(m)$7.58M*$5.31M*$5.69M$203.00K$11.52M$24.00K
2019-03-31Reported(m)$2.32M(m)(m)(m)$116.00K$650.00K$5.04M$234.00K$9.46M$138.00K
2018-12-31Reported(m)$2.92M(m)(m)(m)(m)(m)$4.84M$0.00$9.70M$127.00K
2018-09-30Reported(m)$2.51M(m)(m)(m)$1.52M*$5.16M*$4.10M$0.00$9.46M$35.00K
2018-06-30Reported(m)$2.29M(m)(m)(m)(m)(m)$4.18M$0.00$7.89M$0.00
2018-03-31Reported(m)$2.34M(m)(m)(m)(m)(m)$3.56M$0.00$7.26M$0.00

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$51.56M(m)(m)(m)19.08%$39.98M$51.92M$114.82M$3.02M$121.37M$6.39M
2024-12-31Reported$43.27M(m)(m)(m)19.29%$37.77M$39.09M$91.05M$3.07M$106.20M$4.76M
2023-12-31Reported$36.19M(m)(m)(m)19.78%$26.09M$45.21M$70.22M$2.78M$87.88M$4.15M
2022-12-31Reported$23.88M(m)(m)(m)17.20%$22.90M$27.75M$54.15M$2.70M$68.16M$2.77M
2021-12-31Reported(m)$11.58M(m)(m)(m)$19.74M$22.49M$43.65M$2.11M$54.89M$3.38M
2021-09-30Rolling(m)$12.18M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30Rolling(m)$13.30M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31Rolling(m)$23.50M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31Reported(m)$26.78M(m)(m)(m)$13.04M$35.11M$51.20M$1.08M$52.83M-$5.17M
2020-12-31Rolling(m)$26.78M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Rolling(m)$24.20M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30Rolling(m)$22.35M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31Rolling(m)$11.16M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31Reported(m)$8.86M(m)(m)(m)$13.38M$19.09M$24.25M$848.00K$41.38M$271.00K
2019-12-31Rolling(m)$8.86M*(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Rolling(m)$9.08M*(m)(m)(m)(m)(m)$21.89M*$645.00K*$40.90M*$340.00K*
2019-06-30Rolling(m)$9.41M*(m)(m)(m)(m)(m)$19.67M*$437.00K*$40.13M*$324.00K*
2019-03-31Rolling(m)$10.03M*(m)(m)(m)(m)(m)$18.17M*$234.00K*$36.51M*$300.00K*
2018-12-31Reported(m)$10.06M(m)(m)(m)$6.11M$22.37M$16.69M$0.00$34.30M$162.00K
2018-12-31Rolling(m)$10.06M*(m)(m)(m)(m)(m)$16.69M*$0.00*$34.30M*$162.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Park Dental Partners, Inc. (PARK)United States$0.094B
BioRestorative Therapies, Inc. (BRTX)United States$0.064B
CRYO CELL INTERNATIONAL INC (CCEL)United States$0.033B-11.02
MANGOCEUTICALS, INC. (MGRX)United States$0.010B-0.43
agilon health, inc. (AGL)United States$1.272B-7.76
Progyny, Inc. (PGNY)United States$1.994B28.37
Sotera Health Co (SHC)United States$5.271B30.96
DAVITA INC. (DVA)United States$11.147B16.80